NSCLC, STAGE III

Clinical trials for NSCLC, STAGE III explained in plain language.

Never miss a new study

Get alerted when new NSCLC, STAGE III trials appear

Sign up with your email to follow new studies for NSCLC, STAGE III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 1 Not yet finished but already full! 2 Completed 1

New hope for inoperable lung cancer: experimental combo shows promise

Disease control Completed

This study tested whether adding two new drugs (GFH018 and toripalimab) to standard chemotherapy and radiation could better control advanced, inoperable stage III lung cancer. It involved 65 patients who had not received prior treatment for this stage of cancer. The main goal was…

Matched conditions: NSCLC, STAGE III

Phase: PHASE2 • Sponsor: Genfleet Therapeutics (Shanghai) Inc. • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

NSCLC, STAGE III

Get alerted when new NSCLC, STAGE III trials appear

New hope for inoperable lung cancer: experimental combo shows promise